Iovance Biotherapeutics Inc

Financials

Flusso di cassa derivante dalle attività operative -205.13 M-227.94 M-292.76 M-361.82 M-352.98 M-302.41 M -302.41 M Flussi di cassa derivanti dalle attività di investimento -317.85 M132 K256.45 M-155.24 M-96.41 M47.5 M 47.5 M Liquidità derivante dalle attività di finanziamento 576.42 M239.27 M190.15 M462.96 M390.66 M300.77 M 300.77 M Liquidità libera -251.93 M-265.51 M-313.18 M-384.11 M-364.05 M-336.24 M -336.24 M

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

IOVA

Financials

Iovance Biotherapeutics Inc

Notizie

Undercovered Stocks: Zscaler, Aeluma, Devon Energy, And More

Jefferies conferma il rating buy su Iovance Biotherapeutics

Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback (NASDAQ:IOVA)

Iovance Biotherapeutics: Competition Afoot, But New Indications Can Help (NASDAQ:IOVA)

Iovance Biotherapeutics (IOVA) Down 2.1% Since Last Earnings Report: Can It Rebound?

Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Wendy Yarno del CdA di Iovance Biotherapeutics si ritira

Iovance Biotherapeutics alla conferenza Barclays: crescita strategica e sfide

Iovance Biotherapeutics at Barclays Conference: Strategic Growth and Challenges

What's Going On With Iovance Biotherapeutics Stock On Friday? - Iovance Biotherapeutics (NASDAQ:IOVA)

Il titolo Iovance Biotherapeutics raggiunge il massimo a 4,35 USD

Iovance Biotherapeutics stock hits 52-week high at 4.35 USD